Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 4/8/20091 min de lectura
Determination of Regulatory Review Period for Purposes of Patent Extension; RECOTHROM
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) has determined the regulatory review period for RECOTHROM and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of three applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of patents which claim that human biological product.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →